Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma
- PMID: 28851662
- DOI: 10.1016/j.humpath.2017.08.016
Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma
Abstract
Programmed cell death 1 receptor (PD-1)/programmed death-1 ligand-1 (PD-L1) interaction has been linked to tumor immune evasion. PD-L1 expression has been indicated in identifying non-small cell lung carcinoma (NSCLC) patients for treatment with anti-PD-1 or anti-PD-L1 therapy. The goal of this study was to evaluate the clinicopathologic values of PD-L1 expression and single-nucleotide polymorphisms (SNPs) in the PD-L1 gene in lung adenocarcinoma (ADC) and squamous cell carcinoma (SqCC). The 147 NSCLC tissues consisted of 84 samples of ADC and 63 samples of SqCC. All tissue microarray paraffin blocks were used for PD-L1 immunohistochemical assays with 22C3, SP263, and SP142 clones. Three SNPs in the PD-L1 gene, rs4143815, rs822336, and rs822337, were genotyped using SNP pyrosequencing. The PD-L1 expression was significantly higher in SqCC than in ADC. Among ADCs, PD-L1 expression was significantly higher in papillary and solid types than in lepidic and acinar types. Statistical associations of the PD-L1 expression with a shorter disease-free survival outcome and lymph node metastasis in the ADCs were found but no associations in SqCCs. Among the three SNPs, the rs4143815 genotype CC was statistically associated with positive 22C3 PD-L1 labeling in NSCLCs. The rs4143815 genotype GG instead showed a trend of shorter survival outcomes but did not reach statistical significance in the ADCs. Our results showed a significantly higher prevalence of positive PD-L1 expression in lung SqCC than in ADC. However, the PD-L1 expression and rs4143815 genotype GG might be useful for the prediction of poor prognosis in lung ADC cases.
Keywords: Adenocarcinoma; Non–small cell lung carcinoma; Programmed cell death 1 receptor; Programmed death-1 ligand-1; Single-nucleotide polymorphism; Squamous cell carcinoma.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples.Clin Lung Cancer. 2017 Nov;18(6):682-691.e5. doi: 10.1016/j.cllc.2017.04.014. Epub 2017 May 4. Clin Lung Cancer. 2017. PMID: 28549836
-
Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.Turk Patoloji Derg. 2017;1(1):211-222. doi: 10.5146/tjpath.2017.01398. Turk Patoloji Derg. 2017. PMID: 28832075 English.
-
Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.Arch Pathol Lab Med. 2017 Nov;141(11):1529-1532. doi: 10.5858/arpa.2017-0028-OA. Epub 2017 Aug 22. Arch Pathol Lab Med. 2017. PMID: 28829153
-
Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.J Clin Oncol. 2017 Dec 1;35(34):3867-3876. doi: 10.1200/JCO.2017.74.7642. Epub 2017 Oct 20. J Clin Oncol. 2017. PMID: 29053400 Review.
-
PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review.Lung Cancer. 2017 Oct;112:200-215. doi: 10.1016/j.lungcan.2017.08.005. Epub 2017 Aug 10. Lung Cancer. 2017. PMID: 29191596 Review.
Cited by
-
The nomogram for the prediction of overall survival in patients with metastatic lung adenocarcinoma undergoing primary site surgery: A retrospective population-based study.Front Oncol. 2022 Aug 15;12:916498. doi: 10.3389/fonc.2022.916498. eCollection 2022. Front Oncol. 2022. PMID: 36033482 Free PMC article.
-
Influence of Programmed Death Ligand-1-Gene Polymorphism rs822336 on the Prognosis and Safety of Postoperative Patients with NSCLC Who Received Platinum-Based Adjuvant Chemotherapy.Cancer Manag Res. 2020 Aug 4;12:6755-6766. doi: 10.2147/CMAR.S255072. eCollection 2020. Cancer Manag Res. 2020. PMID: 32801904 Free PMC article.
-
PD-L1 expression in pleural effusions of pulmonary adenocarcinoma and survival prediction: a controlled study by pleural biopsy.Sci Rep. 2018 Jul 25;8(1):11206. doi: 10.1038/s41598-018-29156-5. Sci Rep. 2018. PMID: 30046124 Free PMC article.
-
PD-L1 expression and tumor mutational burden status for prediction of response to chemotherapy and _targeted therapy in non-small cell lung cancer.J Exp Clin Cancer Res. 2019 May 14;38(1):193. doi: 10.1186/s13046-019-1192-1. J Exp Clin Cancer Res. 2019. PMID: 31088500 Free PMC article.
-
Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma.PeerJ. 2020 May 6;8:e9086. doi: 10.7717/peerj.9086. eCollection 2020. PeerJ. 2020. PMID: 32411535 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials